Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - Elsevier
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke

L Nie, D Yao, S Chen, J Wang, C Pan, D Wu… - Cell Death …, 2023 - nature.com
Due to the limited capacity of the adult mammalian brain to self-repair and regenerate,
neurological diseases, especially neurodegenerative disorders and stroke, characterized by …

3D bioprinting pluripotent stem cell derived neural tissues using a novel fibrin bioink containing drug releasing microspheres

R Sharma, IPM Smits, L De La Vega, C Lee… - … in bioengineering and …, 2020 - frontiersin.org
3D bioprinting combines cells with a supportive bioink to fabricate multiscale, multi-cellular
structures that imitate native tissues. Here, we demonstrate how our novel fibrin-based …

Molecular insights into NR4A2 (Nurr1): an emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death

M Jakaria, ME Haque, DY Cho, S Azam, IS Kim… - Molecular …, 2019 - Springer
NR4A2 is a nuclear receptor and a transcription factor, with distinctive physiological
features. In the cell nuclei of the central nervous system, it is widely expressed and identified …

Roles of transcription factors in the development and reprogramming of the dopaminergic neurons

L Tian, M Al-Nusaif, X Chen, S Li, W Le - International Journal of …, 2022 - mdpi.com
The meso-diencephalic dopaminergic (mdDA) neurons regulate various critical processes in
the mammalian nervous system, including voluntary movement and a wide range of …

[HTML][HTML] Generation and characterization of NGLY1 patient-derived midbrain organoids

J Abbott, M Tambe, I Pavlinov, A Farkhondeh… - Frontiers in Cell and …, 2023 - frontiersin.org
NGLY1 deficiency is an ultra-rare, autosomal recessive genetic disease caused by
mutations in the NGLY1 gene encoding N-glycanase 1 that removes N-linked glycans …

Dopaminergic neurons differentiated from LRRK2 I1371V-induced pluripotent stem cells display a lower yield, α-synuclein pathology, and functional impairment

S Jagtap, C Potdar, R Yadav, PK Pal… - ACS Chemical …, 2022 - ACS Publications
Being a large multidomain protein, LRRK2 has several confirmed pathological mutant
variants for PD, and the incidence of these variants shows ethnicity biases. I1371V, a …

Stem Cell-Based Approaches in Parkinson's Disease Research

MS Kim, S Yoon, J Choi, YJ Kim, G Lee - International Journal of …, 2024 - ijstemcell.com
Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of
midbrain dopaminergic neurons, leading to motor symptoms. While current treatments …

Molecular regulation in dopaminergic neuron development. Cues to unveil molecular pathogenesis and pharmacological targets of neurodegeneration

F Volpicelli, C Perrone-Capano, GC Bellenchi… - International Journal of …, 2020 - mdpi.com
The relatively few dopaminergic neurons in the mammalian brain are mostly located in the
midbrain and regulate many important neural functions, including motor integration …

Current state-of-the-art and unresolved problems in using human induced pluripotent stem cell-derived dopamine neurons for parkinson's disease drug development

SA Antonov, EV Novosadova - International Journal of Molecular …, 2021 - mdpi.com
Human induced pluripotent stem (iPS) cells have the potential to give rise to a new era in
Parkinson's disease (PD) research. As a unique source of midbrain dopaminergic (DA) …